Barbara M. Bryant

5.7k total citations · 1 hit paper
27 papers, 2.7k citations indexed

About

Barbara M. Bryant is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Barbara M. Bryant has authored 27 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 12 papers in Hematology and 4 papers in Cancer Research. Recurrent topics in Barbara M. Bryant's work include Multiple Myeloma Research and Treatments (11 papers), Protein Degradation and Inhibitors (11 papers) and Epigenetics and DNA Methylation (6 papers). Barbara M. Bryant is often cited by papers focused on Multiple Myeloma Research and Treatments (11 papers), Protein Degradation and Inhibitors (11 papers) and Epigenetics and DNA Methylation (6 papers). Barbara M. Bryant collaborates with scholars based in United States, United Kingdom and Netherlands. Barbara M. Bryant's co-authors include Deanna A. Mele, Jennifer A. Mertz, Andrew R. Conery, Robert J. Sims, Péter Sandy, Srividya Balasubramanian, Louise Bergeron, Oliver D. King, Gabriel F. Berriz and Frederick P. Roth and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

Barbara M. Bryant

26 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting MYC dependence in cancer by inhibiting BET bromodomains

2011 876 citations Jennifer A. Mertz, Andrew R. Conery et al. Proceedings of the National Academy of Sciences profile →

Peers

Barbara M. Bryant

HEMAT

ONCOL

IMMUN

Emanuela Colombo Italy

K C Anderson United States

Florence Magrangeas France

John R. Mills United States

Ichiro Hanamura Japan

Ronald W. Stam Netherlands

Jian Hou China

Relja Popovic United States

Kimberly A. Lee United States

Sjozèf van Baal Netherlands

Emanuela Colombo Italy

Barbara M. Bryant

2.1k ×0.9

980 ×1.1

HEMAT

545 ×1.1

ONCOL

253 ×1.5

IMMUN

222 ×1.3

Citations per year, relative to Barbara M. Bryant Barbara M. Bryant (= 1×) peers Emanuela Colombo

Countries citing papers authored by Barbara M. Bryant

Since Specialization

Citations

This map shows the geographic impact of Barbara M. Bryant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara M. Bryant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara M. Bryant more than expected).

Fields of papers citing papers by Barbara M. Bryant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara M. Bryant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara M. Bryant. The network helps show where Barbara M. Bryant may publish in the future.

Co-authorship network of co-authors of Barbara M. Bryant

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara M. Bryant. A scholar is included among the top collaborators of Barbara M. Bryant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara M. Bryant. Barbara M. Bryant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bommi‐Reddy, Archana, Esteban Terzo, Florence Poy, et al.. (2019). Abstract 4722: Efficacy of a novel EP300/CBP histone acetyltransferase inhibitor in hormone responsive breast cancer. 4722–4722. 1 indexed citations

Conery, Andrew R., Richard C. Centore, Archana Bommi‐Reddy, et al.. (2016). Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic Response. Cancer Research. 76(6). 1313–1319. 23 indexed citations

McGrath, John P., Kaylyn E. Williamson, Srividya Balasubramanian, et al.. (2016). Pharmacological Inhibition of the Histone Lysine Demethylase KDM1A Suppresses the Growth of Multiple Acute Myeloid Leukemia Subtypes. Cancer Research. 76(7). 1975–1988. 70 indexed citations

Conery, Andrew R., Richard C. Centore, Adrianne Neiss, et al.. (2016). Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma. eLife. 5. 84 indexed citations

Egan, Brian, Chih-Chi Yuan, Madeleine Craske, et al.. (2016). An Alternative Approach to ChIP-Seq Normalization Enables Detection of Genome-Wide Changes in Histone H3 Lysine 27 Trimethylation upon EZH2 Inhibition. PLoS ONE. 11(11). e0166438–e0166438. 85 indexed citations

Mele, Deanna A., Andrés Salmerón, Srimoyee Ghosh, et al.. (2013). BET bromodomain inhibition suppresses TH17-mediated pathology. The Journal of Experimental Medicine. 210(11). 2181–2190. 174 indexed citations

Halbert, Chanita Hughes, Marjorie A. Bowman, Barbara M. Bryant, et al.. (2013). Acceptance of a community-based navigator program for cancer control among urban African Americans. Health Education Research. 29(1). 97–108. 6 indexed citations

LeRoy, Gary, Peter A. DiMaggio, Eric Y. Chan, et al.. (2013). A quantitative atlas of histone modification signatures from human cancer cells. Epigenetics & Chromatin. 6(1). 20–20. 105 indexed citations

Bryant, Barbara M.. (2012). Chromatin Computation. PLoS ONE. 7(5). e35703–e35703. 17 indexed citations

10.

Mertz, Jennifer A., Andrew R. Conery, Barbara M. Bryant, et al.. (2011). Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proceedings of the National Academy of Sciences. 108(40). 16669–16674. 876 indexed citations breakdown →

11.

Goy, André, Steven H. Bernstein, Alice McDonald, et al.. (2010). Potential biomarkers of bortezomib activity in mantle cell lymphoma from the phase 2 PINNACLE trial. Leukemia & lymphoma. 51(7). 1269–1277. 19 indexed citations

12.

Halbert, Chanita Hughes, Shiriki Kumanyika, Marjorie A. Bowman, et al.. (2009). Participation rates and representativeness of African Americans recruited to a health promotion program. Health Education Research. 25(1). 6–13. 15 indexed citations

13.

Bryant, Barbara M.. (2008). How To Advance Open International Scientific Exchange. PLoS Computational Biology. 4(6). e1000097–e1000097. 1 indexed citations

14.

Chng, Wee Joo, Shaji Kumar, Scott VanWier, et al.. (2007). Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling. Cancer Research. 67(7). 2982–2989. 195 indexed citations

15.

Yaturu, Subhashini, Barbara M. Bryant, & Sushil K. Jain. (2007). Thiazolidinedione Treatment Decreases Bone Mineral Density in Type 2 Diabetic Men. Diabetes Care. 30(6). 1574–1576. 120 indexed citations

16.

Chng, Wee Joo, Esteban Braggio, George Mulligan, et al.. (2007). The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibition. Blood. 111(3). 1603–1609. 87 indexed citations

17.

Chng, Wee Joo, George Mulligan, Barbara M. Bryant, & P. Leif Bergsagel. (2006). Survival of Genetic Subtypes of Relapsed Myeloma May Be Modulated by Secondary Events.. Blood. 108(11). 132–132. 3 indexed citations

18.

Lawson, Tracy, Barbara M. Bryant, Stephane C. Lefebvre, J. C. Lloyd, & Christine A. Raines. (2005). Decreased SBPase activity alters growth and development in transgenic tobacco plants. Plant Cell & Environment. 29(1). 48–58. 40 indexed citations

19.

Berriz, Gabriel F., Oliver D. King, Barbara M. Bryant, Chris Sander, & Frederick P. Roth. (2003). Characterizing gene sets with FuncAssociate. Bioinformatics. 19(18). 2502–2504. 350 indexed citations

20.

Chen, Martin K. & Barbara M. Bryant. (1975). The Measurement of Health—A Critical and Selective Overview. International Journal of Epidemiology. 4(4). 257–264. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact